Effectiveness of Chiropractic Application for Acute Low Back Pain

Effectiveness of Chiropractic Application in Patients With Acute Low Back Pain Presenting to the Emergency Department and Receiving Drug Treatment

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04110119

Enrollment

Registered

2019-10-01

Start date

2018-10-01

Completion date

2019-12-01

Last updated

2021-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Mechanical

Keywords

Mechanical Low Back Pain, Chiropractics, Analgesic-anti-inflammatory, myorelaxant, Thiocolchicoside

Brief summary

The aim of this project is to investigate the effectiveness of chiropractic application on patients who have undergone routine medication as a standard hospital treatment for mechanical low-back pain as described in the Clinical Practice Guidelines

Interventions

DRUGdiclophenac sodium (75 mg, IM) and thiocolchicoside (4 mg, IM)

Single intramuscular injection of mixture of two commercial drugs (Analgesic-anti-inflammatory and myorelaxant) at the specified dosages

OTHERChiropractic Treatment

High speed and low amplitude spinal manipulation techniques are applied to the case group.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

19 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Aged between 19 and 65. * Acute lower-back pain, persisting less than 6 weeks, meeting the diagnostic classification of 1 or 2 according to the Quebec Task Force on Spinal Disorders

Exclusion criteria

* Previous spine surgery * Spinal nerve root irritation or deficits, * Pregnant women, * Lower-back pain due to occupational accidents * Obesity status (body mass index\> 30). * Chronic lower-back pain longer than 6 weeks.

Design outcomes

Primary

Measure	Time frame	Description
Change in pain level	Up to 5 minutes	Visual Analogue Pain Scale (VAS) assessment at the fifth minute after the injection of drug. Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It uses a ten centimeter scale with a minimum of 0 indicating no pain and a maximum of 10 indicating worst pain.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026